PeproTech Inc.
Originally published online as doi:10.1189/jlb.1107782 on March 10, 2008

Published online before print March 10, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1107782v1
83/6/1323    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shao, D. D.
Right arrow Articles by Pilling, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shao, D. D.
Right arrow Articles by Pilling, D.
Related Collections
Right arrowRelated Article
(Journal of Leukocyte Biology. 2008;83:1323-1333.)
© 2008 by Society for Leukocyte Biology

Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation

Diane D. Shao, Rahul Suresh, Varsha Vakil, Richard H. Gomer and Darrell Pilling1

Department of Biochemistry and Cell Biology, Rice University, Houston, Texas, USA

1Correspondence: Department of Biochemistry and Cell Biology, MS-140, Rice University, South Main Street, Houston, TX 77005-1894, USA. E-mail: dpilling{at}rice.edu

ABSTRACT

CD14+ peripheral blood monocytes can differentiate into fibroblast-like cells called fibrocytes, which are associated with and are at least partially responsible for wound healing and fibrosis in multiple organ systems. Signals regulating fibrocyte differentiation are poorly understood. In this study, we find that when added to human PBMCs cultured in serum-free medium, the profibrotic cytokines IL-4 and IL-13 promote fibrocyte differentiation without inducing fibrocyte or fibrocyte precursor proliferation. We also find that the potent, antifibrotic cytokines IFN-{gamma} and IL-12 inhibit fibrocyte differentiation. In our culture system, IL-1β, IL-3, IL-6, IL-7, IL-16, GM-CSF, M-CSF, fetal liver tyrosine kinase 3, insulin growth factor 1, vascular endothelial growth factor, and TNF-{alpha} had no significant effect on fibrocyte differentiation. IL-4, IL-13, and IFN-{gamma} act directly on monocytes to regulate fibrocyte differentiation, and IL-12 acts indirectly, possibly through CD16-positive NK cells. We previously identified the plasma protein serum amyloid P (SAP) as a potent inhibitor of fibrocyte differentiation. When added together, the fibrocyte-inhibitory activity of SAP dominates the profibrocyte activities of IL-4 and IL-13. The profibrocyte activities of IL-4 and IL-13 and the fibrocyte-inhibitory activities of IFN-{gamma} and IL-12 counteract each other in a concentration-dependent manner. These results indicate that the complex mix of cytokines and plasma proteins present in inflammatory lesions, wounds, and fibrosis will influence fibrocyte differentiation.

Key Words: fibrosis • inflammation • monocytes • pentraxin • serum amyloid P


Related Article

Cytokines and fibrocyte differentiation—altering the balance: an interview with Dr. Darrell Pilling
Helene F. Rosenberg
J. Leukoc. Biol. 2008 83: 1334-1335. [Full Text] [PDF]